In 2014, 14.5 million people in the United States had cancer. How patient information and data is handled in the medical system is rarely thought about until someone or a loved one gets the dreaded diagnosis. Eric Lefofsky, co-founder of Tempus, wants to make patient care data-driven and tailored to each patient on a molecular level.
Despite advances in technology with the advent of electronic health records, how medical data is collected and analyzed is far from how effective it could be. Tempus does not just want to change what we do with the large amounts of information that is already collected, their loftiest goal may be making patients’ complete genetic makeup part of their medical record that is regularly referenced and cross referenced by scientists and doctors from around the globe. A process that in 2003 was done for more than one hundred million, the current expenditure is only around five thousand and is expected to be around a few hundred within the next several years.
Eric Lefkofsky is a Detroit native with a Bachelor of Arts and a Juris Doctor from the University of Michigan. He is best known as the co-founder of groupon, but as of 2015 he resigned from his position of Chief Executive Officer to Chairman of Groupon and is now able to better relegate time to his many other projects. Lefkofsky also co-founded the company Lightbank, the company Tempus operaes under. Lightbank is an investment firm that specializes in backing disruptive technology startups that are generally not based in Silicon Valley.
Lefkofsky taught disruptive business models at Northwestern University’s Kellogg School of Management as well as applied technology at Kellstadt Graduate School of Business at Depaul University. He currently holds the position of adjunct professor at the University of Chicago Booth School of Business, teaching a course on technology-based business entrepreneurship. He currently acts as a board member at World Business Chicago and is the co-chairman of the Technology Council.